查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1662686

福斯高林市場預測至 2030 年：按來源、形式、濃度、應用、最終用戶和地區進行的全球分析

Forskolin Market Forecasts to 2030 - Global Analysis by Source (Natural and Synthetic), Form (Powder, Capsules/Tablets, Liquid and Raw Extract), Concentration, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球福斯高林市場價值為 5.832 億美元，預計到 2030 年將達到 10.2205 億美元，預測期內的複合年成長率為 9.8%。

福斯可林是一種天然化合物，來自薄荷家族的毛喉鞘蕊花（Coleus forskohlii）植物的根。它傳統上在阿育吠陀醫學中用於多種健康益處。福斯可林以其能夠提高體內環磷酸腺苷 (cAMP) 的水平而聞名，環磷酸腺苷是一種在調節許多生理過程方面發揮作用的分子，包括脂肪分解、心臟功能和免疫反應。福斯可林通常作為減肥補充劑出售，儘管支持其有效性的研究有限。人們也正在研究它在治療心臟病、氣喘和青光眼的潛在用途。

據悉，美國是北美地區福斯高林的主要市場，佔90%以上的市場佔有率。

對天然補充品的需求不斷增加

對天然補充劑的需求不斷成長，對福斯可林市場產生了重大影響。福斯可林衍生毛喉鞘蕊花植物，因其天然的體重管理、抗發炎和心臟健康功效而越來越受到追捧。隨著消費者青睞植物性和有機產品，福斯可林在膳食補充劑、減重產品和健康解決方案中的受歡迎程度持續成長。對天然健康解決方案的追求以及對福斯高林益處的認知不斷提高，推動了零售和健康領域的需求，從而促進了市場擴張。

產品成本高

產品成本高是福斯高林產業的一個主要障礙，限制了消費者的取得並減少了需求。保持產品價格低廉並維持利潤率對於製造商來說是一個挑戰。此外，高成本帶來的價格戰可能會趕走規模較小的競爭對手。即使福斯可林產品在健康和保健行業中越來越受歡迎，這也可能限制其潛在影響力，尤其是在價格敏感的國家，並阻礙整體市場的成長。

健身與健康領域熱門

健身和健康趨勢日益流行，極大地推動了福斯可林市場的發展，因為人們越來越認知到它對減重、減脂和增強肌肉質量的潛在益處。隨著消費者的健康意識不斷增強，對福斯可林等天然補充品的需求正在激增。此外，線上健康社群、健身影響者和健康計畫的興起進一步推動了人們對基於福斯可林的產品的認知和採用。預計這一趨勢將持續下去，推動健身和健康領域的市場成長。

副作用和安全問題

由於使用過程中產生的副作用和安全問題，福斯可林市場面臨障礙。低血壓、心率加快和消化器官系統問題等潛在副作用可能會阻礙消費者的採用。此外，缺乏足夠的法律規範和關於其有效性和安全性的不一致的臨床證據可能會引起消費者和醫療專業人士的懷疑。這些因素導致市場成長緩慢，各地區接受度謹慎。

COVID-19 的影響

COVID-19 疫情對亞太地區福斯高林市場產生了負面影響，擾亂了供應鏈，並因經濟不確定性限制了消費者支出。然而，在疫情期間，人們對健康和免疫支持的關注度增加，導致對包括福斯可林在內的天然補充劑的需求增加。網路分銷管道的日益重要以及消費者對健康和體重管理興趣的增加促進了市場的逐步復甦。

營養補充品市場預計將在預測期內實現最大幅度成長

由於消費者對自然有效的體重管理、燃脂和整體健康解決方案的需求不斷成長，預計膳食補充劑領域將在預測期內佔據最大的市場佔有率。福斯可林在補充劑中很受歡迎，尤其是它具有促進新陳代謝、促進脂肪減少和支持心血管健康的潛力，促進了市場的成長。隨著消費者擴大尋求植物性和整體性的合成產品替代品，膳食補充劑行業正在進一步擴大，加速了對各種健康相關配方中福斯可林的需求。

預測期內，青光眼領域預計將以最高複合年成長率成長

在預測期內，由於福斯可林的潛在治療益處，預計青光眼領域將呈現最高的成長率。研究表明，福斯可林有助於降低眼壓，這是青光眼管理的重要因素。因此，福斯可林作為青光眼的天然替代療法或補充治療方法越來越受到關注。青光眼的發生率不斷上升，尤其是在老齡人口中，以及人們對草藥治療眼部健康的興趣日益濃厚，推動了市場對以福斯可林為基礎的解決方案的需求，從而促進了其在醫療保健領域的擴張。

比最大的地區

在預測期內，由於膳食補充劑（尤其是減脂和增肌膳食補充劑）的日益普及，預計北美地區將佔據最大的市場佔有率，從而支持對基於福斯高林的產品的需求。注重健康的消費者擴大提倡在保健補充劑中使用福斯可林，並選擇植物性的天然補充劑。此外，人們越來越意識到福斯可林在改善心臟健康和控制肥胖方面的潛在益處，這進一步推動了北美市場的成長，特別是在飲食和健身補充劑領域。

複合年成長率最高的地區

在預測期內，由於人們對健康和保健趨勢的認知不斷增強，預計亞太地區將呈現最高的複合年成長率。可支配收入的增加和更健康的生活方式的轉變進一步促進了市場的成長。在印度和中國等國家的傳統醫療實踐的支持下，草藥補充劑行業的擴張也刺激了對以福斯可林為基礎的補充劑的需求。此外，福斯可林因其對心血管健康和減肥有潛在益處而廣受歡迎，這也推動了其在該地區的市場滲透。

提供免費客製化

本報告的每位客戶都將獲得以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 主要企業的 SWOT 分析（最多 3 家公司）
  • 地理細分
    • 根據客戶興趣對主要國家進行市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭性基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第 2 章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二手研究資料資訊來源
    • 先決條件

第3章 市場走勢分析

  • 介紹
  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第 4 章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球福斯高林市場依來源分類

  • 介紹
  • 自然的
  • 合成

6. 全球福斯高林市場按形式

  • 介紹
  • 粉末
  • 膠囊/錠劑
  • 液體
  • 原料萃取物

7. 全球福斯高林市場實力

  • 介紹
  • 低濃度（10%）
  • 中等濃度（20% 至 40%）
  • 高濃度（95%）

8. 全球福斯高林市場（按應用）

  • 介紹
  • 過敏治療
  • 體重管理
  • 呼吸問題
  • 心血管疾病
  • 青光眼
  • 甲狀腺機能低下症
  • 乾癬
  • 其他

第 9 章 全球福斯高林市場（按最終用戶）

  • 介紹
  • 營養補充品
  • 藥品
  • 營養補充品
  • 食品加工
  • 化妝品
  • 其他

第 10 章 全球福斯高林市場（按地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Acumen Pharmaceuticals, Inc.
  • Alchem International Ltd.
  • Bio-gen Extracts Pvt. Ltd.
  • Biosynthesis Inc.
  • Cayman Chemical Company
  • Changsha Staherb Natural Ingredients Co., Ltd.
  • ChromaDex, Inc.
  • Hunan Nutramax Inc.
  • Indena SpA
  • Indofine Chemical Company, Inc.
  • LGM Pharma
  • LKT Laboratories, Inc.
  • MediHerb Pty Ltd.
  • Nutra Green BIoTechnology Co., Ltd.
  • Sabinsa Corporation
  • Shaanxi Green Bio-Engineering Co., Ltd.
  • Sigma-Aldrich Corporation
  • TCI America
  • Xi'an Natural Field Bio-Technique Co., Ltd.
Product Code: SMRC28547

According to Stratistics MRC, the Global Forskolin Market is accounted for $583.2 million in 2024 and is expected to reach $1022.05 million by 2030 growing at a CAGR of 9.8% during the forecast period. Forskolin is a natural compound derived from the root of the Coleus forskohlii plant, which belongs to the mint family. It has been traditionally used in Ayurvedic medicine for various health benefits. Forskolin is known for its ability to increase levels of cyclic AMP (cAMP) in the body, a molecule that plays a role in regulating many physiological processes, including fat breakdown, heart function, and immune response. Forskolin is commonly marketed as a weight loss supplement, though research supporting its effectiveness for this purpose is limited. It is also being investigated for potential uses in managing heart disease, asthma, and glaucoma.

According to reports, the United States is the dominant market for forskolin in North America, accounting for over 90% of the market share.

Market Dynamics:

Driver:

Increasing Demand for Natural Supplements

The rising demand for natural supplements is significantly impacting the Forskolin market. Forskolin, derived from the Coleus forskohlii plant, is increasingly sought after due to its natural weight management, anti-inflammatory, and heart health benefits. As consumers prefer plant-based and organic products, Forskolin's popularity in dietary supplements, weight loss products, and wellness solutions continues to grow. The trend towards natural health solutions, along with rising awareness of the benefits of Forskolin, is fostering market expansion, driving demand in both the retail and wellness sectors.

Restraint:

High Product Costs

High product costs are a key barrier in the Forskolin industry, limiting consumer access and reducing demand. Maintaining profit margins while keeping product prices low may be challenging for manufacturers. Furthermore, price rivalry brought on by high expenses may drive out smaller competitors. Even if forskolin products are becoming more and more well-liked in the health and wellness industry, this might restrict their potential reach and impede overall market growth, particularly in price-sensitive countries.

Opportunity:

Popularity in Fitness and Wellness

The growing popularity of fitness and wellness trends is significantly driving the Forskolin market, as it is increasingly recognized for its potential benefits in weight loss, fat reduction, and enhancing muscle mass. As consumers become more health-conscious, the demand for natural supplements like Forskolin has surged. Additionally, the rise of online health communities, fitness influencers, and wellness programs further boosts the awareness and adoption of Forskolin-based products. This trend is expected to continue, fueling market growth in the fitness and wellness sector.

Threat:

Side Effects and Safety Concerns

The Forskolin market faces hindrance due to side effects and safety concerns associated with its use. Potential side effects such as low blood pressure, increased heart rate, and digestive issues can deter consumer adoption. Additionally, the lack of sufficient regulatory oversight and inconsistent clinical evidence regarding its effectiveness and safety may raise doubts among consumers and healthcare professionals. These factors contribute to slower market growth and cautious acceptance in various regions.

Covid-19 Impact:

The COVID-19 pandemic negatively impacted the Forskolin market in Asia-Pacific, disrupting supply chains and limiting consumer spending due to economic uncertainty. However, the increased focus on health and immune support during the pandemic led to a rise in demand for natural supplements, including Forskolin. Online sales channels gained prominence, contributing to the market's gradual recovery as consumer interest in wellness and weight management grew.

The dietary supplements segment is expected to be the largest during the forecast period

The dietary supplements segment is expected to account for the largest market share during the forecast period, due to rising consumer demand for natural and effective weight management, fat burning, and overall health solutions. Forskolin's popularity in supplements, particularly for its potential to enhance metabolism, promote fat loss, and support cardiovascular health, is contributing to market growth. As consumers increasingly seek plant-based and holistic alternatives to synthetic products, the dietary supplement sector is expanding, further accelerating the demand for Forskolin in various health-related formulations.

The glaucoma segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the glaucoma segment is predicted to witness the highest growth rate due to Forskolin's potential therapeutic benefits. Research suggests that Forskolin can help reduce intraocular pressure, a key factor in glaucoma management. As a result, Forskolin is gaining attention as a natural alternative or complementary treatment for glaucoma. The growing prevalence of glaucoma, particularly in aging populations, alongside increasing interest in herbal remedies for eye health, is driving the demand for Forskolin-based solutions in the market, contributing to its expansion in the healthcare sector.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to increasing popularity of dietary supplements, especially for fat loss and muscle building, supports demand for Forskolin-based products. Health-conscious consumers are increasingly opting for plant-based, natural alternatives, propelling Forskolin's use in wellness supplements. Additionally, the expanding awareness of Forskolin's potential benefits in improving heart health and managing obesity further drives its market growth in North America, particularly in the dietary and fitness supplement sectors.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to growing awareness of health and wellness trends. Rising disposable incomes and a shift toward healthier lifestyles further contribute to the market's growth. The expanding herbal supplement industry, supported by traditional medicine practices in countries like India and China, also fuels the demand for Forskolin-based supplements. Additionally, the popularity of Forskolin for its potential benefits in cardiovascular health and fat loss drives its market penetration in the region.

Key players in the market

Some of the key players in Forskolin market include Acumen Pharmaceuticals, Inc., Alchem International Ltd., Bio-gen Extracts Pvt. Ltd., Biosynthesis Inc., Cayman Chemical Company, Changsha Staherb Natural Ingredients Co., Ltd., ChromaDex, Inc., Hunan Nutramax Inc., Indena S.p.A., Indofine Chemical Company, Inc., LGM Pharma, LKT Laboratories, Inc, MediHerb Pty Ltd., Nutra Green Biotechnology Co., Ltd., Sabinsa Corporation, Shaanxi Green Bio-Engineering Co., Ltd., Sigma-Aldrich Corporation, TCI America and Xi'an Natural Field Bio-Technique Co., Ltd.

Key Developments:

In September 2024, Acumen Pharmaceuticals, Inc. announced that it has extended its collaboration with Lonza to enable the potential future commercial launch of sabirnetug (ACU193).

In September 2024, Cayman Chemical and Certest Pharma announced a new partnership to make Certest proprietary ionizable lipids available for LNP research through Cayman's online catalog and global network of distributors.

In November 2023, Acumen Pharmaceuticals, Inc. announced non-exclusive collaboration and license agreement with Halozyme Therapeutics Inc. The collaboration will provide Acumen access to Halozyme's ENHANZE drug delivery technology, for the development of a subcutaneous formulation of ACU193, the first clinical-stage ABO-targeting antibody.

Sources Covered:

  • Natural
  • Synthetic

Forms Covered:

  • Powder
  • Capsules/Tablets
  • Liquid
  • Raw Extract

Concentrations Covered:

  • Low Concentration (10%)
  • Medium Concentration (20% to 40%)
  • High Concentration (95%)

Applications Covered:

  • Allergy Treatment
  • Weight Management
  • Respiratory Problems
  • Cardiovascular Disorders
  • Glaucoma
  • Hypothyroidism
  • Psoriasis
  • Other Applications

End Users Covered:

  • Nutraceuticals
  • Pharmaceutical
  • Dietary Supplements
  • Food Processing
  • Cosmetics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Forskolin Market, By Source

  • 5.1 Introduction
  • 5.2 Natural
  • 5.3 Synthetic

6 Global Forskolin Market, By Form

  • 6.1 Introduction
  • 6.2 Powder
  • 6.3 Capsules/Tablets
  • 6.4 Liquid
  • 6.5 Raw Extract

7 Global Forskolin Market, By Concentration

  • 7.1 Introduction
  • 7.2 Low Concentration (10%)
  • 7.3 Medium Concentration (20% to 40%)
  • 7.4 High Concentration (95%)

8 Global Forskolin Market, By Application

  • 8.1 Introduction
  • 8.2 Allergy Treatment
  • 8.3 Weight Management
  • 8.4 Respiratory Problems
  • 8.5 Cardiovascular Disorders
  • 8.6 Glaucoma
  • 8.7 Hypothyroidism
  • 8.8 Psoriasis
  • 8.9 Other Applications

9 Global Forskolin Market, By End User

  • 9.1 Introduction
  • 9.2 Nutraceuticals
  • 9.3 Pharmaceutical
  • 9.4 Dietary Supplements
  • 9.5 Food Processing
  • 9.6 Cosmetics
  • 9.7 Other End Users

10 Global Forskolin Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Acumen Pharmaceuticals, Inc.
  • 12.2 Alchem International Ltd.
  • 12.3 Bio-gen Extracts Pvt. Ltd.
  • 12.4 Biosynthesis Inc.
  • 12.5 Cayman Chemical Company
  • 12.6 Changsha Staherb Natural Ingredients Co., Ltd.
  • 12.7 ChromaDex, Inc.
  • 12.8 Hunan Nutramax Inc.
  • 12.9 Indena S.p.A.
  • 12.10 Indofine Chemical Company, Inc.
  • 12.11 LGM Pharma
  • 12.12 LKT Laboratories, Inc.
  • 12.13 MediHerb Pty Ltd.
  • 12.14 Nutra Green Biotechnology Co., Ltd.
  • 12.15 Sabinsa Corporation
  • 12.16 Shaanxi Green Bio-Engineering Co., Ltd.
  • 12.17 Sigma-Aldrich Corporation
  • 12.18 TCI America
  • 12.19 Xi'an Natural Field Bio-Technique Co., Ltd.

List of Tables

  • Table 1 Global Forskolin Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Forskolin Market Outlook, By Source (2022-2030) ($MN)
  • Table 3 Global Forskolin Market Outlook, By Natural (2022-2030) ($MN)
  • Table 4 Global Forskolin Market Outlook, By Synthetic (2022-2030) ($MN)
  • Table 5 Global Forskolin Market Outlook, By Form (2022-2030) ($MN)
  • Table 6 Global Forskolin Market Outlook, By Powder (2022-2030) ($MN)
  • Table 7 Global Forskolin Market Outlook, By Capsules/Tablets (2022-2030) ($MN)
  • Table 8 Global Forskolin Market Outlook, By Liquid (2022-2030) ($MN)
  • Table 9 Global Forskolin Market Outlook, By Raw Extract (2022-2030) ($MN)
  • Table 10 Global Forskolin Market Outlook, By Concentration (2022-2030) ($MN)
  • Table 11 Global Forskolin Market Outlook, By Low Concentration (10%) (2022-2030) ($MN)
  • Table 12 Global Forskolin Market Outlook, By Medium Concentration (20% to 40%) (2022-2030) ($MN)
  • Table 13 Global Forskolin Market Outlook, By High Concentration (95%) (2022-2030) ($MN)
  • Table 14 Global Forskolin Market Outlook, By Application (2022-2030) ($MN)
  • Table 15 Global Forskolin Market Outlook, By Allergy Treatment (2022-2030) ($MN)
  • Table 16 Global Forskolin Market Outlook, By Weight Management (2022-2030) ($MN)
  • Table 17 Global Forskolin Market Outlook, By Respiratory Problems (2022-2030) ($MN)
  • Table 18 Global Forskolin Market Outlook, By Cardiovascular Disorders (2022-2030) ($MN)
  • Table 19 Global Forskolin Market Outlook, By Glaucoma (2022-2030) ($MN)
  • Table 20 Global Forskolin Market Outlook, By Hypothyroidism (2022-2030) ($MN)
  • Table 21 Global Forskolin Market Outlook, By Psoriasis (2022-2030) ($MN)
  • Table 22 Global Forskolin Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 23 Global Forskolin Market Outlook, By End User (2022-2030) ($MN)
  • Table 24 Global Forskolin Market Outlook, By Nutraceuticals (2022-2030) ($MN)
  • Table 25 Global Forskolin Market Outlook, By Pharmaceutical (2022-2030) ($MN)
  • Table 26 Global Forskolin Market Outlook, By Dietary Supplements (2022-2030) ($MN)
  • Table 27 Global Forskolin Market Outlook, By Food Processing (2022-2030) ($MN)
  • Table 28 Global Forskolin Market Outlook, By Cosmetics (2022-2030) ($MN)
  • Table 29 Global Forskolin Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.